Silver Book Fact

The total economic burden of coronary heart disease is $120.6 billion; of stroke is $48.9 billion.

Cutler D, Long G, Berndt E, Royer J, et al. The Value Of Antihypertensive Drugs: A perspective on medical innovation. Health Affairs. 2007; 26(1): 97-110

Reference

Title
The Value Of Antihypertensive Drugs: A perspective on medical innovation
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Cutler D, Long G, Berndt E, Royer J, et al.
Volume & Issue
Volume 26, Issue 1
Pages
97-110

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • People who survive the acute stage of a myocardial infarction have a chance of illness and death that is 1.5 to 15 times higher than the general population.  
  • Approximately 1 in 3 adults has high blood pressure (HBP) which, if not properly diagnosed and treated, can lead to heart failure, heart attack, stroke, blindness, and kidney disease.  
  • VTE incidence, 2003
    Venous thromboembolism occurs for the first time in around 100 per 100,000 people each year.  
  • The mortality rate due to cardiovascular disease was 235.5 per 100,000 people in 2010.  
  • As many as 5 million Americans are diagnosed with heart valve disease each year.